• Fathelrahman M Hassan, Afnan A Alsultan, Faisal Alzahrani, Waleed H Albuali, Dalal K Bubshait, Elfadil M Abass, Mudathir A Elbasheer, and Abdulmohsen A Alkhanbashi.
• From the Department of Clinical Laboratory Sciences (Hassan, Alsultan, Alzahrani, Abass, Elbasheer, Alkhanbashi), College of Applied Medical Sciences; and from the Department of Pediatrics (Albuali, Bubshait), College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia.
• Saudi Med J. 2021 Sep 1; 42 (9): 969-974.

ObjectivesTo identify ribosome protein L5 gene variants and the risk of hepatic vein thrombosis in Saudi patients.MethodsA case-control study was conducted during the period of May 2018 to September 2019. Sixty-five patient cases of hepatic vein thrombosis (HVT) were chosen, and 50 healthy individuals of the same ages and both gender were set as a control group. The genotype of the gene RPL5 was determined by PCR please provide abbreviation in full and capillary electrophoresis. Sanger sequencing for genetically screened variants was applied for the RPL5 gene.ResultsAlleles A at variant rs182018447 and T allele at variant rs559377519 were strongly corelated (p=0.009 and p=0.037, respectively) with the risk of HVT. The genotype frequencies of the RPL5 gene, the A/A genotypes at rs182018447 and T/T at rs559377519 were associated with HVT (p=0.000 and p=0.004; respectively) and an increase in risk for HVT among these patients. Please rephrase the highlighted text without using the word respectively.ConclusionOur findings indicate that the 5 genetic novel variants examined in the RPL5 gene were associated with a risk of HVT in all our Saudi cases. Additionally, the A/A at rs182018447 and T/T at rs559377519 genotypes were substantially susceptible to HVT in all these patients.Copyright: © Saudi Medical Journal.

17 keywords...

hide…